Literature DB >> 29108454

PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer.

Prerna Malaney1, Emily Palumbo1, Jonathan Semidey-Hurtado1, Jamaal Hardee1, Katherine Stanford1, Jaymin J Kathiriya1, Deepal Patel1, Zhi Tian2, Diane Allen-Gipson2, Vrushank Davé1,3.   

Abstract

PTEN phosphorylation at its C-terminal (C-tail) serine/threonine cluster negatively regulates its tumor suppressor function. However, the consequence of such inhibition and its downstream effects in driving lung cancer remain unexplored. Herein, we ascertain the molecular mechanisms by which phosphorylation compromises PTEN function, contributing to lung cancer. Replacement of the serine/threonine residues with alanine generated PTEN-4A, a phosphorylation-deficient PTEN mutant, which suppressed lung cancer cell proliferation and migration. PTEN-4A preferentially localized to the nucleus where it suppressed E2F1-mediated transcription of cell cycle genes. PTEN-4A physically interacted with the transcription factor E2F1 and associated with chromatin at gene promoters with E2F1 DNA-binding sites, a likely mechanism for its transcriptional suppression function. Deletion analysis revealed that the C2 domain of PTEN was indispensable for suppression of E2F1-mediated transcription. Further, we uncovered cancer-associated C2 domain mutant proteins that had lost their ability to suppress E2F1-mediated transcription, supporting the concept that these mutations are oncogenic in patients. Consistent with these findings, we observed increased PTEN phosphorylation and reduced nuclear PTEN levels in lung cancer patient samples establishing phosphorylation as a bona fide inactivation mechanism for PTEN in lung cancer. Thus, use of small molecule inhibitors that hinder PTEN phosphorylation is a plausible approach to activate PTEN function in the treatment of lung cancer. Abbreviations AKT V-Akt Murine Thymoma Viral Oncogene CA Cancer adjacent CDK1 Cyclin dependent kinase 1 CENPC-C Centromere Protein C ChIP Chromatin Immunoprecipitation co-IP Co-immunoprecipitation COSMIC Catalog of Somatic Mutations In Cancer CREB cAMP Responsive Element Binding Protein C-tail Carboxy terminal tail E2F1 E2F Transcription Factor 1 ECIS Electric Cell-substrate Impedance Sensing EGFR Epidermal Growth Factor Receptor GSI Gamma Secretase Inhibitor HDAC1 Histone Deacetylase 1 HP1 Heterochromatin protein 1 KAP1/TRIM28 KRAB-Associated Protein 1/Tripartite Motif Containing 28 MAF1 Repressor of RNA polymerase III transcription MAF1 homolog MCM2 Minichromosome Maintenance Complex Component 2 miRNA micro RNA MTF1 Metal-Regulatory Transcription Factor 1 PARP Poly(ADP-Ribose) Polymerase PD-1 Programmed Cell Death 1 PD-L1 Programmed Cell Death 1 Ligand 1 PI3K Phosphatidylinositol-4,5-Bisphosphate 3-Kinase PLK Polo-like Kinase pPTEN Phosphorylated PTEN PTEN Phosphatase and Tensin Homolog deleted on chromosome ten PTM Post Translational Modification Rad51 RAD51 Recombinase Rad52 RAD52 Recombinase RPA1 Replication protein A SILAC Stable Isotope Labeling with Amino Acids in Cell Culture SRF Serum Response Factor TKI Tyrosine Kinase inhbitors TMA Tissue Microarray TOP2A DNA Topoisomerase 2A.

Entities:  

Keywords:  E2F1; PTEN; lung cancer; phosphorylation; transcription

Mesh:

Substances:

Year:  2018        PMID: 29108454      PMCID: PMC6103743          DOI: 10.1080/15384101.2017.1388970

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  90 in total

1.  Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells.

Authors:  Margaret E Ginn-Pease; Charis Eng
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

Review 2.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

Review 3.  Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer.

Authors:  Claudia Fumarola; Mara A Bonelli; Pier Giorgio Petronini; Roberta R Alfieri
Journal:  Biochem Pharmacol       Date:  2014-05-24       Impact factor: 5.858

4.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

Authors:  H Sun; R Lesche; D M Li; J Liliental; H Zhang; J Gao; N Gavrilova; B Mueller; X Liu; H Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.

Authors:  Shigehisa Yanagi; Hiroyuki Kishimoto; Kohichi Kawahara; Takehiko Sasaki; Masato Sasaki; Miki Nishio; Nobuyuki Yajima; Koichi Hamada; Yasuo Horie; Hiroshi Kubo; Jeffrey A Whitsett; Tak Wah Mak; Toru Nakano; Masamitsu Nakazato; Akira Suzuki
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

6.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function.

Authors:  M P Myers; I Pass; I H Batty; J Van der Kaay; J P Stolarov; B A Hemmings; M H Wigler; C P Downes; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

7.  PTEN Controls the DNA Replication Process through MCM2 in Response to Replicative Stress.

Authors:  Jiawen Feng; Jing Liang; Jiaju Li; Yunqiao Li; Hui Liang; Xuyang Zhao; Michael A McNutt; Yuxin Yin
Journal:  Cell Rep       Date:  2015-11-05       Impact factor: 9.423

8.  Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors.

Authors:  Kyle A Edgar; Jeffrey J Wallin; Megan Berry; Leslie B Lee; Wei Wei Prior; Deepak Sampath; Lori S Friedman; Marcia Belvin
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

9.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

10.  PTEN inhibits BMI1 function independently of its phosphatase activity.

Authors:  Catherine Fan; Lizhi He; Anil Kapoor; Adrian P Rybak; Jason De Melo; Jean-Claude Cutz; Damu Tang
Journal:  Mol Cancer       Date:  2009-11-10       Impact factor: 27.401

View more
  11 in total

1.  PTEN as a Guardian of the Genome: Pathways and Targets.

Authors:  Xinyi Fan; Jeffrey Kraynak; Jonathan P S Knisely; Silvia C Formenti; Wen H Shen
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 6.915

2.  Structural and Dynamic Effects of PTEN C-Terminal Tail Phosphorylation.

Authors:  Iris N Smith; Jennifer E Dawson; James Krieger; Stetson Thacker; Ivet Bahar; Charis Eng
Journal:  J Chem Inf Model       Date:  2022-08-24       Impact factor: 6.162

3.  Neddylation of PTEN regulates its nuclear import and promotes tumor development.

Authors:  Ping Xie; Zhiqiang Peng; Yujiao Chen; Hongchang Li; Mengge Du; Yawen Tan; Xin Zhang; Zhe Lu; Chun-Ping Cui; Cui Hua Liu; Fuchu He; Lingqiang Zhang
Journal:  Cell Res       Date:  2020-12-09       Impact factor: 46.297

Review 4.  PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?

Authors:  Nicola Fusco; Elham Sajjadi; Konstantinos Venetis; Gabriella Gaudioso; Gianluca Lopez; Chiara Corti; Elena Guerini Rocco; Carmen Criscitiello; Umberto Malapelle; Marco Invernizzi
Journal:  Genes (Basel)       Date:  2020-06-28       Impact factor: 4.096

5.  miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN.

Authors:  Wei Du; Xu Zhang; Zhen Wan
Journal:  Onco Targets Ther       Date:  2019-06-21       Impact factor: 4.147

Review 6.  PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around.

Authors:  Anastasios Gkountakos; Giulia Sartori; Italia Falcone; Geny Piro; Ludovica Ciuffreda; Carmine Carbone; Giampaolo Tortora; Aldo Scarpa; Emilio Bria; Michele Milella; Rafael Rosell; Vincenzo Corbo; Sara Pilotto
Journal:  Cancers (Basel)       Date:  2019-08-09       Impact factor: 6.639

7.  PTEN Inhibition Protects Against Experimental Intracerebral Hemorrhage-Induced Brain Injury Through PTEN/E2F1/β-Catenin Pathway.

Authors:  Dan Zhao; Xing-Ping Qin; Song-Feng Chen; Xin-Yu Liao; Jing Cheng; Rui Liu; Yang Lei; Zhi-Feng Zhang; Qi Wan
Journal:  Front Mol Neurosci       Date:  2019-12-05       Impact factor: 5.639

8.  WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11.

Authors:  Shuqin Xing; Yafei Wang; Kaiwen Hu; Fen Wang; Tao Sun; Quanwang Li
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

9.  Phosphatase and Tensin Homolog (PTEN) of Japanese Flounder-Its Regulation by miRNA and Role in Autophagy, Apoptosis and Pathogen Infection.

Authors:  Wenrui Li; Xiaolu Guan; Li Sun
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

10.  TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT-GSK-3β-β-Catenin Signaling Pathway.

Authors:  Shiyu Chen; Zhiwei He; Changhao Zhu; Yanqing Liu; Lin Li; Lu Deng; Jun Wang; Chao Yu; Chengyi Sun
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.